579 related articles for article (PubMed ID: 27157611)
1. Hsa-miR-24-3p increases nasopharyngeal carcinoma radiosensitivity by targeting both the 3'UTR and 5'UTR of Jab1/CSN5.
Wang S; Pan Y; Zhang R; Xu T; Wu W; Zhang R; Wang C; Huang H; Calin CA; Yang H; Claret FX
Oncogene; 2016 Nov; 35(47):6096-6108. PubMed ID: 27157611
[TBL] [Abstract][Full Text] [Related]
2. Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression.
Pan Y; Wang S; Su B; Zhou F; Zhang R; Xu T; Zhang R; Leventaki V; Drakos E; Liu W; Claret FX
Oncogene; 2017 Feb; 36(8):1069-1079. PubMed ID: 27524414
[TBL] [Abstract][Full Text] [Related]
3. Suppression of Jab1/CSN5 induces radio- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways.
Pan Y; Zhang Q; Atsaves V; Yang H; Claret FX
Oncogene; 2013 May; 32(22):2756-66. PubMed ID: 22797071
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis.
Huang T; Yin L; Wu J; Gu JJ; Wu JZ; Chen D; Yu HL; Ding K; Zhang N; Du MY; Qian LX; Lu ZW; He X
J Exp Clin Cancer Res; 2016 Dec; 35(1):188. PubMed ID: 27919278
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancer.
Wang S; Oh DY; Leventaki V; Drakos E; Zhang R; Sahin AA; Resetkova E; Edgerton ME; Wu W; Claret FX
Cancer Lett; 2019 Nov; 465():12-23. PubMed ID: 31473252
[TBL] [Abstract][Full Text] [Related]
6. MiRNA-203 Reduces Nasopharyngeal Carcinoma Radioresistance by Targeting IL8/AKT Signaling.
Qu JQ; Yi HM; Ye X; Zhu JF; Yi H; Li LN; Xiao T; Yuan L; Li JY; Wang YY; Feng J; He QY; Lu SS; Xiao ZQ
Mol Cancer Ther; 2015 Nov; 14(11):2653-64. PubMed ID: 26304234
[TBL] [Abstract][Full Text] [Related]
7. Curcumin analogue T83 exhibits potent antitumor activity and induces radiosensitivity through inactivation of Jab1 in nasopharyngeal carcinoma.
Pan Y; Wang M; Bu X; Zuo Y; Wang S; Wang D; Liu Q; Su B; Xu T; Wang C; Claret FX; Yang H
BMC Cancer; 2013 Jul; 13():323. PubMed ID: 23815987
[TBL] [Abstract][Full Text] [Related]
8. MiR-23a sensitizes nasopharyngeal carcinoma to irradiation by targeting IL-8/Stat3 pathway.
Qu JQ; Yi HM; Ye X; Li LN; Zhu JF; Xiao T; Yuan L; Li JY; Wang YY; Feng J; He QY; Lu SS; Yi H; Xiao ZQ
Oncotarget; 2015 Sep; 6(29):28341-56. PubMed ID: 26314966
[TBL] [Abstract][Full Text] [Related]
9. MiR-17-5p promotes cancer cell proliferation and tumorigenesis in nasopharyngeal carcinoma by targeting p21.
Chen C; Lu Z; Yang J; Hao W; Qin Y; Wang H; Xie C; Xie R
Cancer Med; 2016 Dec; 5(12):3489-3499. PubMed ID: 27774777
[TBL] [Abstract][Full Text] [Related]
10. MiR-125b Increases Nasopharyngeal Carcinoma Radioresistance by Targeting A20/NF-κB Signaling Pathway.
Li LN; Xiao T; Yi HM; Zheng Z; Qu JQ; Huang W; Ye X; Yi H; Lu SS; Li XH; Xiao ZQ
Mol Cancer Ther; 2017 Oct; 16(10):2094-2106. PubMed ID: 28698199
[TBL] [Abstract][Full Text] [Related]
11. Targeting Jab1/CSN5 in nasopharyngeal carcinoma.
Pan Y; Claret FX
Cancer Lett; 2012 Dec; 326(2):155-60. PubMed ID: 22867945
[TBL] [Abstract][Full Text] [Related]
12. microRNA-124 inhibits stem-like properties and enhances radiosensitivity in nasopharyngeal carcinoma cells via direct repression of expression of JAMA.
Tian Y; Tian Y; Tu Y; Zhang G; Zeng X; Lin J; Ai M; Mao Z; Zheng R; Yuan Y
J Cell Mol Med; 2020 Sep; 24(17):9533-9544. PubMed ID: 32681617
[TBL] [Abstract][Full Text] [Related]
13. MiR-24 enhances radiosensitivity in nasopharyngeal carcinoma by targeting SP1.
Kang M; Xiao J; Wang J; Zhou P; Wei T; Zhao T; Wang R
Cancer Med; 2016 Jun; 5(6):1163-73. PubMed ID: 26922862
[TBL] [Abstract][Full Text] [Related]
14. MiR-101 sensitizes human nasopharyngeal carcinoma cells to radiation by targeting stathmin 1.
Sun Q; Liu T; Zhang T; Du S; Xie GX; Lin X; Chen L; Yuan Y
Mol Med Rep; 2015 May; 11(5):3330-6. PubMed ID: 25607713
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of lncRNA ANRIL inhibits proliferation, induces apoptosis, and enhances radiosensitivity in nasopharyngeal carcinoma cells through regulating miR-125a.
Hu X; Jiang H; Jiang X
Cancer Biol Ther; 2017 May; 18(5):331-338. PubMed ID: 28402230
[TBL] [Abstract][Full Text] [Related]
16. miR-150 contributes to the radioresistance in nasopharyngeal carcinoma cells by targeting glycogen synthase kinase-3β.
Huang Y; Tan D; Xiao J; Li Q; Zhang X; Luo Z
J Cancer Res Ther; 2018 Jan; 14(1):111-118. PubMed ID: 29516971
[TBL] [Abstract][Full Text] [Related]
17. MiR-451 increases radiosensitivity of nasopharyngeal carcinoma cells by targeting ras-related protein 14 (RAB14).
Zhang T; Sun Q; Liu T; Chen J; Du S; Ren C; Liao G; Yuan Y
Tumour Biol; 2014 Dec; 35(12):12593-9. PubMed ID: 25201065
[TBL] [Abstract][Full Text] [Related]
18. MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma.
Jiang N; Jiang X; Chen Z; Song X; Wu L; Zong D; Song D; Yin L; Wang D; Chen C; Bian X; He X
J Exp Clin Cancer Res; 2017 Oct; 36(1):138. PubMed ID: 28982387
[TBL] [Abstract][Full Text] [Related]
19. miR-483-5p decreases the radiosensitivity of nasopharyngeal carcinoma cells by targeting DAPK1.
Tian Y; Yan M; Zheng J; Li R; Lin J; Xu A; Liang Y; Zheng R; Yuan Y
Lab Invest; 2019 May; 99(5):602-611. PubMed ID: 30664712
[TBL] [Abstract][Full Text] [Related]
20. miR‑495 enhances the efficacy of radiotherapy by targeting GRP78 to regulate EMT in nasopharyngeal carcinoma cells.
Feng X; Lv W; Wang S; He Q
Oncol Rep; 2018 Sep; 40(3):1223-1232. PubMed ID: 30015969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
